Recent Progress in CRISPR/Cas9 Technology

Journal of Genetics and Genomics

Volumn 43, Issue 2, 2016, Pages 63-75

  Mei, Yue ^a,b   Wang, Yan ^a   Chen, Huiqian ^c   Sun, Zhong Sheng ^a,c   Ju, Xing Da ^d  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

^d NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

CRISPR Cas9; Epigenome editing; Genome editing; RNA editing

Indexed keywords

BIOSAFETY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; EPIGENETICS; GENOME; PROTEIN MODIFICATION; CHEMISTRY; CRISPR CAS SYSTEM; GENE EDITING; GENETICS; METABOLISM; MUTATION; PROTEIN DOMAIN;

CRISPR ASSOCIATED PROTEIN; DEOXYRIBONUCLEASE;

CRISPR-ASSOCIATED PROTEINS; CRISPR-CAS SYSTEMS; ENDODEOXYRIBONUCLEASES; GENE EDITING; MUTATION; PROTEIN DOMAINS;

EID: 84968324811     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2016.01.001     Document Type: Review

References (90)

1. Aida T., Chiyo K., Usami T., Ishikubo H., Imahashi R., Wada Y., Tanaka K.F., Sakuma T., Yamamoto T., Tanaka K. Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice. Genome Biol. 2015, 16:87.
2. Baltimore D., Berg P., Botchan M., Carroll D., Charo R.A., Church G., Corn J.E., Daley G.Q., Doudna J.A., Fenner M., Greely H.T., Jinek M., Martin G.S., Penhoet E., Puck J., Sternberg S.H., Weissman J.S., Yamamoto K.R. Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science 2015, 348:36-38.
3. Bassett A.R., Kong L., Liu J.L. A genome-wide CRISPR library for high-throughput genetic screening in Drosophila cells. J. Genet. Genomics 2015, 42:301-309.
4. Bassett A.R., Tibbit C., Ponting C.P., Liu J.L. Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep. 2013, 4:220-228.
5. Bedell V.M., Wang Y., Campbell J.M., Poshusta T.L., Starker C.G., Krug R.G., Tan W., Penheiter S.G., Ma A.C., Leung A.Y., Fahrenkrug S.C., Carlson D.F., Voytas D.F., Clark K.J., Essner J.J., Ekker S.C. In vivo genome editing using a high-efficiency TALEN system. Nature 2012, 491:114-118.
6. Bohannon J. Biotechnology. Biologists devise invasion plan for mutations. Science 2015, 347. 1300-1300.
7. Chang N., Sun C., Gao L., Zhu D., Xu X., Zhu X., Xiong J.W., Xi J.J. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res. 2013, 23:465-472.
8. Cho S.W., Kim S., Kim Y., Kweon J., Kim H.S., Bae S., Kim J.S. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res. 2014, 24:132-141.
9. Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
10. Datsenko K.A., Pougach K., Tikhonov A., Wanner B.L., Severinov K., Semenova E. Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat. Commun. 2012, 3:945.
11. Dickinson D.J., Ward J.D., Reiner D.J., Goldstein B. Engineering the C. elegans genome using Cas9-triggered homologous recombination. Nat. Methods 2013, 10:1028-1034.
12. Dong C., Qu L., Wang H., Wei L., Dong Y., Xiong S. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication. Antiviral Res. 2015, 118:110-117.
13. Friedland A.E., Tzur Y.B., Esvelt K.M., Colaiacovo M.P., Church G.M., Calarco J.A. Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat. Methods 2013, 10:741-743.
14. Fu Y., Sander J.D., Reyon D., Cascio V.M., Joung J.K. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 2014, 32:279-284.
15. Fujii W., Onuma A., Sugiura K., Naito K. Efficient generation of genome-modified mice via offset-nicking by CRISPR/Cas system. Biochem. Biophys. Res. Commun. 2014, 445:791-794.
16. Fujii W., Onuma A., Sugiura K., Naito K. One-step generation of phenotype-expressing triple-knockout mice with heritable mutated alleles by the CRISPR/Cas9 system. J. Reprod. Dev. 2014, 60:324-327.
17. Fujita T., Fujii H. Efficient isolation of specific genomic regions and identification of associated proteins by engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) using CRISPR. Biochem. Biophys. Res. Commun. 2013, 439:132-136.
18. Gantz V.M., Bier E. The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations. Science 2015, 348:442-444.
19. Gilbert L.A., Larson M.H., Morsut L., Liu Z.R., Brar G.A., Torres S.E., Stern-Ginossar N., Brandman O., Whitehead E.H., Doudna J.A., Lim W.A., Weissman J.S., Qi L.S. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013, 154:442-451.
20. Gratz S.J., Cummings A.M., Nguyen J.N., Hamm D.C., Donohue L.K., Harrison M.M., Wildonger J., O'Connor-Giles K.M. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 2013, 194:1029-1035.
21. Han J., Zhang J., Chen L., Shen B., Zhou J., Hu B., Du Y., Tate P.H., Huang X., Zhang W. Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9. RNA Biol. 2014, 11:829-835.
22. Heintze J., Luft C., Ketteler R. A CRISPR CASe for high-throughput silencing. Front. Genet. 2013, 4:193.
23. Hemphill J., Borchardt E.K., Brown K., Asokan A., Deiters A. Optical control of CRISPR/Cas9 gene editing. J. Am. Chem. Soc. 2015, 137:5642-5645.
24. Hilton I.B., D'Ippolito A.M., Vockley C.M., Thakore P.I., Crawford G.E., Reddy T.E., Gersbach C.A. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 2015, 33:510-517.
25. Hsu P.D., Lander E.S., Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014, 157:1262-1278.
26. Hwang W.Y., Fu Y., Reyon D., Maeder M.L., Tsai S.Q., Sander J.D., Peterson R.T., Yeh J.R., Joung J.K. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 2013, 31:227-229.
27. Hyun Y., Kim J., Cho S., Choi Y., Kim J.S., Coupland G. Site-directed mutagenesis in Arabidopsis thaliana using dividing tissue-targeted RGEN of the CRISPR/Cas system to generate heritable null alleles. Planta 2015, 241:271-284.
28. Jao L.E., Wente S.R., Chen W. Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc. Natl. Acad. Sci. USA 2013, 110:13904-13909.
29. Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J.A., Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337:816-821.
30. Kim D., Bae S., Park J., Kim E., Kim S., Yu H.R., Hwang J., Kim J.I., Kim J.S. Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat. Methods 2015, 12:237-243. 231 p following 243.
31. Kleinstiver B.P., Prew M.S., Tsai S.Q., Topkar V.V., Nguyen N.T., Zheng Z., Gonzales A.P., Li Z., Peterson R.T., Yeh J.R., Aryee M.J., Joung J.K. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 2015, 523:481-485.
32. Larson M.H., Gilbert L.A., Wang X., Lim W.A., Weissman J.S., Qi L.S. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 2013, 8:2180-2196.
33. Lawhorn I.E., Ferreira J.P., Wang C.L. Evaluation of sgRNA target sites for CRISPR-mediated repression of TP53. PLoS One 2014, 9:e113232.
34. Levy A., Goren M.G., Yosef I., Auster O., Manor M., Amitai G., Edgar R., Qimron U., Sorek R. CRISPR adaptation biases explain preference for acquisition of foreign DNA. Nature 2015, 520:505-510.
35. Li D., Qiu Z., Shao Y., Chen Y., Guan Y., Liu M., Li Y., Gao N., Wang L., Lu X., Zhao Y., Liu M. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat. Biotechnol. 2013, 31:681-683.
36. Li F., Cowley D.O., Banner D., Holle E., Zhang L., Su L. Efficient genetic manipulation of the NOD-Rag1-/-IL2RgammaC-null mouse by combining in vitro fertilization and CRISPR/Cas9 technology. Sci. Rep. 2014, 4:5290.
37. Li J., Shou J., Guo Y., Tang Y., Wu Y., Jia Z., Zhai Y., Chen Z., Xu Q., Wu Q. Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9. J. Mol. Cell Biol. 2015, 7:284-298.
38. Li W., Teng F., Li T., Zhou Q. Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat. Biotechnol. 2013, 31:684-686.
39. Liang P.P., Xu Y.W., Zhang X.Y., Ding C.H., Huang R., Zhang Z., Lv J., Xie X.W., Chen Y.X., Li Y.J., Sun Y., Bai Y.F., Songyang Z., Ma W.B., Zhou C.Q., Huang J.J. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 2015, 6:363-372.
40. Liao H.K., Gu Y., Diaz A., Marlett J., Takahashi Y., Li M., Suzuki K., Xu R., Hishida T., Chang C.J., Esteban C.R., Young J., Izpisua Belmonte J.C. Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells. Nat. Commun. 2015, 6:6413.
41. Liao J., Karnik R., Gu H., Ziller M.J., Clement K., Tsankov A.M., Akopian V., Gifford C.A., Donaghey J., Galonska C., Pop R., Reyon D., Tsai S.Q., Mallard W., Joung J.K., Rinn J.L., Gnirke A., Meissner A. Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells. Nat. Genet. 2015, 47:469-478.
42. Lin S., Staahl B.T., Alla R.K., Doudna J.A. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. eLife 2014, 3:e04766.
43. Ma S., Chang J., Wang X., Liu Y., Zhang J., Lu W., Gao J., Shi R., Zhao P., Xia Q. CRISPR/Cas9 mediated multiplex genome editing and heritable mutagenesis of BmKu70 in Bombyx mori. Sci. Rep. 2014, 4:4489.
44. Maddalo D., Manchado E., Concepcion C.P., Bonetti C., Vidigal J.A., Han Y.C., Ogrodowski P., Crippa A., Rekhtman N., de Stanchina E., Lowe S.W., Ventura A. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 2014, 516:423-427.
45. Mali P., Yang L.H., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., Norville J.E., Church G.M. RNA-Guided human genome engineering via Cas9. Science 2013, 339:823-826.
46. Maruyama T., Dougan S.K., Truttmann M.C., Bilate A.M., Ingram J.R., Ploegh H.L. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat. Biotechnol. 2015, 33:538-542.
47. Mashiko D., Young S.A., Muto M., Kato H., Nozawa K., Ogawa M., Noda T., Kim Y.J., Satouh Y., Fujihara Y., Ikawa M. Feasibility for a large scale mouse mutagenesis by injecting CRISPR/Cas plasmid into zygotes. Dev. Growth Differ. 2014, 56:122-129.
48. Matsunaga T., Yamashita J.K. Single-step generation of gene knockout-rescue system in pluripotent stem cells by promoter insertion with CRISPR/Cas9. Biochem. Biophys. Res. Commun. 2014, 444:158-163.
49. Nihongaki Y., Yamamoto S., Kawano F., Suzuki H., Sato M. CRISPR-Cas9-based photoactivatable transcription system. Chem. Biol. 2015, 22:169-174.
50. Nishimasu H., Ran F.A., Hsu P.D., Konermann S., Shehata S.I., Dohmae N., Ishitani R., Zhang F., Nureki O. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 2014, 156:935-949.
51. O'Connell M.R., Oakes B.L., Sternberg S.H., East-Seletsky A., Kaplan M., Doudna J.A. Programmable RNA recognition and cleavage by CRISPR/Cas9. Nature 2014, 516:263-266.
52. Ota S., Hisano Y., Ikawa Y., Kawahara A. Multiple genome modifications by the CRISPR/Cas9 system in zebrafish. Genes Cells 2014, 19:555-564.
53. Parikh B.A., Beckman D.L., Patel S.J., White J.M., Yokoyama W.M. Detailed phenotypic and molecular analyses of genetically modified mice generated by CRISPR-Cas9-mediated editing. PLoS One 2015, 10:e0116484.
54. Pefanis E., Wang J.G., Rothschild G., Lim J., Kazadi D., Sun J.B., Federation A., Chao J., Elliott O., Liu Z.P., Economides A.N., Bradner J.E., Rabadan R., Basu U. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell 2015, 161:774-789.
55. Platt R.J., Chen S.D., Zhou Y., Yim M.J., Swiech L., Kempton H.R., Dahlman J.E., Parnas O., Eisenhaure T.M., Jovanovic M., Graham D.B., Jhunjhunwala S., Heidenreich M., Xavier R.J., Langer R., Anderson D.G., Hacohen N., Regev A., Feng G.P., Sharp P.A., Zhang F. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 2014, 159:440-455.
56. Polstein L.R., Gersbach C.A. A light-inducible CRISPR-Cas9 system for control of endogenous gene activation. Nat. Chem. Biol. 2015, 11:198-200.
57. Qin W., Dion S.L., Kutny P.M., Zhang Y., Cheng A.W., Jillette N.L., Malhotra A., Geurts A.M., Chen Y.G., Wang H. Efficient CRISPR/Cas9-mediated genome editing in mice by zygote electroporation of nuclease. Genetics 2015, 200:423-430.
58. Qin W.N., Kutny P., Dion S., Zhang Y.F., Wang H.Y. One-step generation of mice carrying gene-edited alleles by the CRISPR/Cas-mediated genome engineering with high efficiency. Transgenic Res. 2014, 23. 879-879.
59. Ran F.A., Cong L., Yan W.X., Scott D.A., Gootenberg J.S., Kriz A.J., Zetsche B., Shalem O., Wu X., Makarova K.S., Koonin E.V., Sharp P.A., Zhang F. In vivo genome editing using Staphylococcus aureus Cas9. Nature 2015, 520:186-191.
60. Ran F.A., Hsu P.D., Lin C.Y., Gootenberg J.S., Konermann S., Trevino A.E., Scott D.A., Inoue A., Matoba S., Zhang Y., Zhang F. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 2013, 154:1380-1389.
61. Ran F.A., Hsu P.D., Wright J., Agarwala V., Scott D.A., Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013, 8:2281-2308.
62. Ratz M., Testa I., Hell S.W., Jakobs S. CRISPR/Cas9-mediated endogenous protein tagging for RESOLFT super-resolution microscopy of living human cells. Sci. Rep. 2015, 5:9592.
63. Rodriguez E., Keiser M., McLoughlin H., Zhang F., Davidson B.L. AAV-CRISPR: a new therapeutic approach to nucleotide repeat diseases. Mol. Ther. 2014, 22. S94-S94.
64. Rojas-Fernandez A., Herhaus L., Macartney T., Lachaud C., Hay R.T., Sapkota G.P. Rapid generation of endogenously driven transcriptional reporters in cells through CRISPR/Cas9. Sci. Rep. 2015, 5:9811.
65. Sapranauskas R., Gasiunas G., Fremaux C., Barrangou R., Horvath P., Siksnys V. The Streptococcus thermophilus CRISPR/Cas system provides immunity in E. coli. Nucleic Acids Res. 2011, 39:9275-9282.
66. Senis E., Fatouros C., Grosse S., Wiedtke E., Niopek D., Mueller A.K., Borner K., Grimm D. An AAV vector toolbox for CRISPR/Cas9-mediated genome engineering. Hum. Gene Ther. 2014, 25:A24-A25.
67. Seruggia D., Fernandez A., Cantero M., Pelczar P., Montoliu L. Functional validation of mouse tyrosinase non-coding regulatory DNA elements by CRISPR-Cas9-mediated mutagenesis. Nucleic Acids Res. 2015, 43:4855-4867.
68. Shen B., Zhang J., Wu H., Wang J., Ma K., Li Z., Zhang X., Zhang P., Huang X. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res. 2013, 23:720-723.
69. Shen B., Zhang W., Zhang J., Zhou J., Wang J., Chen L., Wang L., Hodgkins A., Iyer V., Huang X., Skarnes W.C. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat. Methods 2014, 11:399-402.
70. Singh P., Schimenti J.C., Bolcun-Filas E. A mouse geneticist's practical guide to CRISPR applications. Genetics 2015, 199:1-15.
71. Swiech L., Heidenreich M., Banerjee A., Habib N., Li Y., Trombetta J., Sur M., Zhang F. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat. Biotechnol. 2015, 33:102-106.
72. Tanenbaum M.E., Gilbert L.A., Qi L.S., Weissman J.S., Vale R.D. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 2014, 159:635-646.
73. Urnov F.D., Miller J.C., Lee Y.L., Beausejour C.M., Rock J.M., Augustus S., Jamieson A.C., Porteus M.H., Gregory P.D., Holmes M.C. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005, 435:646-651.
74. Wang H., Yang H., Shivalila C.S., Dawlaty M.M., Cheng A.W., Zhang F., Jaenisch R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 2013, 153:910-918.
75. Wang J.W., Wang A., Li K.Y., Wang B.M., Jin S.Q., Reiser M., Lockey R.F. CRISPR/Cas9 nuclease cleavage combined with Gibson assembly for seamless cloning. BioTechniques 2015, 58:161-170.
76. Wang Z.P., Xing H.L., Dong L., Zhang H.Y., Han C.Y., Wang X.C., Chen Q.J. Egg cell-specific promoter-controlled CRISPR/Cas9 efficiently generates homozygous mutants for multiple target genes in Arabidopsis in a single generation. Genome Biol. 2015, 16:144.
77. Westra E.R., Semenova E., Datsenko K.A., Jackson R.N., Wiedenheft B., Severinov K., Brouns S.J. Type I-E CRISPR-Cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition. PLoS Genet. 2013, 9:e1003742.
78. Wu X., Scott D.A., Kriz A.J., Chiu A.C., Hsu P.D., Dadon D.B., Cheng A.W., Trevino A.E., Konermann S., Chen S., Jaenisch R., Zhang F., Sharp P.A. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol. 2014, 32:670-676.
79. Wu Y.X., Liang D., Wang Y.H., Bai M.Z., Tang W., Bao S.M., Yan Z.Q., Li D.S., Li J.S. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell 2013, 13:659-662.
80. Xu J., Ren X., Sun J., Wang X., Qiao H.H., Xu B.W., Liu L.P., Ni J.Q. A toolkit of CRISPR-based genome editing systems in Drosophila. J. Genet. Genomics 2015, 42:141-149.
81. Xue W., Chen S., Yin H., Tammela T., Papagiannakopoulos T., Joshi N.S., Cai W., Yang G., Bronson R., Crowley D.G., Zhang F., Anderson D.G., Sharp P.A., Jacks T. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature 2014, 514:380-384.
82. Yang H., Wang H., Shivalila C.S., Cheng A.W., Shi L., Jaenisch R. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 2013, 154:1370-1379.
83. Yin H., Xue W., Chen S., Bogorad R.L., Benedetti E., Grompe M., Koteliansky V., Sharp P.A., Jacks T., Anderson D.G. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 2014, 32:551-553.
84. Yu Z., Ren M., Wang Z., Zhang B., Rong Y.S., Jiao R., Gao G. Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila. Genetics 2013, 195:289-291.
85. Zhang L.Q., Jia R.R., Palange N.J., Satheka A.C., Togo J., An Y., Humphrey M., Ban L.Y., Ji Y., Jin H.H., Feng X.C., Zheng Y.W. Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9. PLoS One 2015, 10:e0120396.
86. Zhang X.X. Urgency to rein in the gene-editing technology. Protein Cell 2015, 6. 313-313.
87. Zhang Z.Q., Xu K., Xin Y., Zhang Z.Y. An efficient method for multiple site-directed mutagenesis using type IIs restriction enzymes. Anal. Biochem. 2015, 476:26-28.
88. Zhong H., Chen Y.Y., Li Y.M., Chen R., Mardon G. CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes. Sci. Rep. 2015, 5:8366.
89. Zhou J., Shen B., Zhang W., Wang J., Yang J., Chen L., Zhang N., Zhu K., Xu J., Hu B., Leng Q., Huang X. One-step generation of different immunodeficient mice with multiple gene modifications by CRISPR/Cas9 mediated genome engineering. Int. J. Biochem. Cell Biol. 2014, 46:49-55.
90. Zhu X., Xu Y., Yu S., Lu L., Ding M., Cheng J., Song G., Gao X., Yao L., Fan D., Meng S., Zhang X., Hu S., Tian Y. An efficient genotyping method for genome-modified animals and human cells generated with CRISPR/Cas9 system. Sci. Rep. 2014, 4:6420.